The Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The company trades at a negative Price/Book ratio of -0.02, signaling deep financial distress or asset write-downs. Despite modest revenue growth of 3.2% YoY and positive gross margins, profitability remains weak with a 0.95% net margin and no ROE or ROIC data. The stock has declined sharply across all timeframes, with a 46% drop over the past year and a half, reflecting persistent market skepticism. The absence of analyst coverage, dividend, and technical momentum further reinforces a bearish outlook.